These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31555735)

  • 1. BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers.
    Kuznetsov JN; Aguero TH; Owens DA; Kurtenbach S; Field MG; Durante MA; Rodriguez DA; King ML; Harbour JW
    Sci Adv; 2019 Sep; 5(9):eaax1738. PubMed ID: 31555735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
    Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
    BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
    Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
    Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma.
    Kuznetsoff JN; Owens DA; Lopez A; Rodriguez DA; Chee NT; Kurtenbach S; Bilbao D; Roberts ER; Volmar CH; Wahlestedt C; Brothers SP; Harbour JW
    Mol Cancer Res; 2021 Feb; 19(2):215-222. PubMed ID: 33077485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
    Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
    Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
    Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
    J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma.
    Han A; Chua V; Baqai U; Purwin TJ; Bechtel N; Hunter E; Tiago M; Seifert E; Speicher DW; Schug ZT; Harbour JW; Aplin AE
    Oncogene; 2022 Feb; 41(8):1129-1139. PubMed ID: 35046531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures.
    Li J; Cao D; Jiang L; Zheng Y; Shao S; Zhuang A; Xiang D
    Cell Oncol (Dordr); 2024 Jun; 47(3):951-965. PubMed ID: 38150154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
    Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
    BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the timing of BAP1 mutation in uveal melanoma progression.
    Uner OE; See TRO; Szalai E; Grossniklaus HE; Stålhammar G
    Sci Rep; 2021 Apr; 11(1):8923. PubMed ID: 33903674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress.
    Chua V; Lopez-Anton M; Mizue Terai ; Ryota Tanaka ; Baqai U; Purwin TJ; Haj JI; Waltrich FJ; Trachtenberg I; Luo K; Tudi R; Jeon A; Han A; Chervoneva I; Davies MA; Aguirre-Ghiso JA; Sato T; Aplin AE
    Sci Signal; 2024 Jun; 17(840):eadn8376. PubMed ID: 38861613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
    Glasgow BJ; McCannel TA
    Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer.
    Boru G; Grosel TW; Pilarski R; Stautberg M; Massengill JB; Jeter J; Singh A; Marino MJ; McElroy JP; Davidorf FH; Cebulla CM; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2019 Sep; 58(9):650-656. PubMed ID: 30883995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA; Bourne TD; Murali R
    Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
    Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
    J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.
    Landreville S; Agapova OA; Matatall KA; Kneass ZT; Onken MD; Lee RS; Bowcock AM; Harbour JW
    Clin Cancer Res; 2012 Jan; 18(2):408-16. PubMed ID: 22038994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.